Loading...
Metabolic Capacity Expansion And Peptide Outsourcing Shifts Will Face Headwinds Yet Ultimately Support Upside
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-13.2%7D
0%1Y
-13.2%7D
0%You can edit this narrative until Dec 17 1:05 PM. Then, changes will post as Updates.